Fund HoldingsDecheng Capital LLC

Total Portfolio Value
$731.75M
Total Bought
$625.2K
Total Sold
$11.07M
Net Transaction
-$10.45M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
Nuvation Bio Inc.(NUVB)25,954,43925,954,4390111,345147,42120.15%+36,077
CG ONCOLOGY INC(CGON)6,371,6696,371,6690431,235452,70761.87%+21,473
AARDVARK THERAPEUTICS INC3,917,2993,917,299014,76822,5643.08%+7,795
Aclaris Therapeutics, Inc.(ACRS)4,041,7364,041,736015,15721,3812.92%+6,224
Equillium Inc.(EQ)4,447,3084,447,30808,89514,2311.94%+5,337
Arcus Biosciences, Inc(RCUS)477,819464,779-13,04010,32114,3291.96%+4,008
Zentalis Pharmaceuticals Inc.(ZNTL)1,323,3271,323,32703,0976,4180.88%+3,322
REVOLUTION MEDICINES INC(NSM)(RVMD)93,50052,667-40,8339,0939,8631.35%+771
TANGO THERAPEUTICS INC(TNGX)020,000+20,00006250.09%+625
Pyxis Oncology, Inc (formerly Apexigen)(PYXS)326,810326,81004779840.13%+507
BeyondSpring Inc.(BYSI)3,800,7023,800,70206,2336,6510.91%+418
KRYSTAL BIOTECH INC(KRYS)7,3000-7,3001,8860-1,886
Lyell Immunopharma, Inc.(LYEL)692,050692,050013,8839,7231.33%-4,159
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
325,057176,887-148,17010,4055,9950.82%-4,410
Upstream Bio Inc.(UPB)2,724,8682,724,868024,52418,8562.58%-5,668
Page 1 of 1
Decheng Capital LLC — 13F Holdings — Q2 2026 | TickerTrail